Submyeloablative total body irradiation‐based conditioning and allogeneic stem cell transplantation in high‐risk myeloma with early progression after up‐front autologous transplantation-Reference-Cited by-同舟云学术

Submyeloablative total body irradiation‐based conditioning and allogeneic stem cell transplantation in high‐risk myeloma with early progression after up‐front autologous transplantation

Published:2021-08-24 Issue:1 Volume:196 Page:244-248
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mai Elias K.¹^ORCID,Schmitt Thomas¹,Radujkovic Aleksandar¹,König Laila²^ORCID,Goldschmidt Hartmut¹³,Ho Anthony D.¹,Luft Thomas¹,Müller‐Tidow Carsten¹,Dreger Peter¹,Hegenbart Ute¹,Schönland Stefan O.¹

Affiliation:

1. Department of Internal Medicine V University Hospital Heidelberg HeidelbergGermany

2. Department of Radiation Oncology University Hospital Heidelberg HeidelbergGermany

3. National Center for Tumor Diseases (NCT) Heidelberg Heidelberg Germany

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17779

Reference9 articles.

1. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

2. Treosulfan conditioning for allogeneic transplantation in multiple myeloma – improved overall survival in first line haematopoietic stem cell transplantation – a large retrospective study by the Chronic Malignancies Working Party of the EBMT

3. Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease

4. Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma

5. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation;Transplantation and Cellular Therapy;2023-10